Bradley K Taylor Selected Research

phenylalanyl- cyclo(cysteinyltyrosyl- tryptophyl- ornithyl- threonyl- penicillamine)threoninamide (CTOP)

1/2022	Endogenous µ-opioid receptor activity in the lateral and capsular subdivisions of the right central nucleus of the amygdala prevents chronic postoperative pain.
1/2020	Sex differences in kappa opioid receptor inhibition of latent postoperative pain sensitization in dorsal horn.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bradley K Taylor Research Topics

Disease

31	Pain (Aches) 01/2022 - 08/2003
26	Hyperalgesia 11/2021 - 06/2002
20	Hypersensitivity (Allergy) 01/2022 - 06/2002
15	Neuralgia (Stump Neuralgia) 04/2020 - 03/2004
12	Chronic Pain 11/2021 - 02/2007
9	Inflammation (Inflammations) 01/2022 - 04/2002
6	Postoperative Pain 01/2022 - 02/2014
6	Cold Hypersensitivity 01/2021 - 09/2007
5	Peripheral Nerve Injuries 01/2021 - 03/2004
3	Multiple Sclerosis 01/2018 - 05/2015
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 05/2015
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 03/2016
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 01/2018
2	Ataxia (Dyssynergia) 05/2015 - 12/2009
2	Edema (Dropsy) 06/2004 - 06/2002
1	Surgical Wound 11/2021
1	Myalgia 01/2021
1	Pruritus (Itching) 01/2020
1	Contusions 01/2018
1	Low Back Pain (Lumbago) 01/2018

Drug/Important Bio-Agent (IBA)

11	Analgesics (Analgesic Drugs)IBA 11/2021 - 03/2004
9	Neuropeptide YIBA 01/2021 - 04/2002
8	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 01/2014
6	Opioid Analgesics (Opioids)IBA 11/2016 - 06/2004
5	LigandsIBA 01/2021 - 07/2008
5	PPAR gammaIBA 01/2021 - 06/2002
4	Naltrexone (ReVia)FDA LinkGeneric 01/2022 - 04/2015
4	salicylhydroxamic acid (SHAM)IBA 01/2022 - 07/2012
4	CarrageenanIBA 01/2021 - 06/2002
4	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 04/2020 - 04/2012
4	CalciumIBA 01/2019 - 07/2012
4	Formaldehyde (Formol)FDA Link 01/2018 - 02/2004
4	Naloxone (Narcan)FDA LinkGeneric 11/2016 - 01/2013
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 01/2014
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2021 - 03/2016
3	BIBO 3304IBA 04/2020 - 04/2002
3	Adenylyl Cyclases (Adenylyl Cyclase)IBA 04/2020 - 01/2014
3	Pioglitazone (Actos)FDA Link 01/2019 - 03/2015
3	Pyruvaldehyde (Methylglyoxal)IBA 01/2019 - 03/2016
3	EnzymesIBA 01/2019 - 01/2007
3	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2019 - 01/2015
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2015 - 06/2002
2	Narcotic Antagonists (Opioid Antagonists)IBA 01/2022 - 01/2013
2	phenylalanyl- cyclo(cysteinyltyrosyl- tryptophyl- ornithyl- threonyl- penicillamine)threoninamide (CTOP)IBA 01/2022 - 01/2020
2	AticaprantIBA 11/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2019
2	erythromycin propionate-N-acetylcysteinateIBA 11/2021 - 01/2019
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2021 - 01/2019
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 11/2021 - 01/2020
2	5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanolIBA 11/2021 - 01/2019
2	SaporinsIBA 01/2021 - 10/2019
2	NeurotoxinsIBA 01/2021 - 10/2019
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018 - 09/2007
2	AcetoneIBA 01/2018 - 09/2007
2	Antidepressive Agents (Antidepressants)IBA 01/2018 - 01/2017
2	Protein Isoforms (Isoforms)IBA 01/2017 - 12/2009
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 02/2014
2	Messenger RNA (mRNA)IBA 01/2016 - 03/2004
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2015 - 04/2009
2	Voltage-Gated Sodium ChannelsIBA 10/2014 - 12/2009
2	Freund's AdjuvantIBA 10/2014 - 09/2004
2	Ranolazine FDA Link 10/2014 - 12/2009
2	Pharmaceutical PreparationsIBA 10/2014 - 02/2014
2	Morphine (MS Contin)FDA LinkGeneric 03/2011 - 06/2004
2	PPAR alphaIBA 04/2009 - 06/2002
2	Rosiglitazone (Avandia)FDA Link 07/2008 - 06/2002
2	Substance PIBA 09/2004 - 03/2004
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2022
1	Ondansetron (Zofran)FDA LinkGeneric 01/2022
1	SphingolipidsIBA 01/2022
1	Cyclic AMP (AMP, Cyclic)IBA 11/2021
1	3- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA 11/2021
1	Dizocilpine Maleate (Dizocilpine)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	ProstaglandinsIBA 01/2021
1	NeuropeptidesIBA 01/2021
1	15-deoxyprostaglandin J2IBA 01/2021
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2021
1	TRPA1 Cation ChannelIBA 04/2020
1	norbinaltorphimineIBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	tyrosyl- 1,2,3,4- tetrahydro- 3- isoquinolinecarbonyl- phenylalanyl- phenylalanine (TIPP)IBA 01/2020
1	naltrindoleIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 03/2019
1	Biological ProductsIBA 01/2019
1	1-naphthylacetylspermineIBA 01/2019
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	propionic acid (potassium propionate)IBA 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 01/2019
1	AnkyrinsIBA 01/2019

Therapy/Procedure

8	Analgesia 01/2021 - 06/2004
3	Spinal Injections 01/2022 - 02/2014
3	Drug Therapy (Chemotherapy) 11/2021 - 03/2016
2	Ligation 09/2007 - 03/2004
1	Therapeutics 01/2019
1	Transplantation 01/2018